Directory
>
Karen Bergman
Karen Bergman
Vice President, Communications and Investor Relations | Bolt Biotherapeutics, Inc.
Menlo Park, California, United States
Karen Bergman
Summary
Karen Bergman is a seasoned Vice President specializing in investor relations and corporate communications within the biopharmaceutical and life sciences sectors. With a robust background in crafting strategic narratives and executing high-impact initiatives, she has successfully guided companies from private stages to public offerings. Her expertise encompasses a wide range of areas, including crisis communications, corporate branding, and stakeholder management. Karen's leadership style emphasizes collaboration and strategic foresight, making her a trusted advisor to C-suite executives. She has a proven track record of enhancing corporate reputation and investor engagement, particularly in competitive environments. Her educational foundation from Yale University and the University of Michigan further solidifies her professional acumen. Beyond her corporate roles, she has served on advisory boards, contributing to the advancement of industry standards. Karen's passion for life sciences drives her commitment to innovative communication strategies that resonate with diverse audiences.
Karen Bergman
Work Experience
Vice President, Communications and Investor Relations at
Bolt Biotherapeutics, Inc.
January 2021 - Present
Strategic Communications and Investor Relations Consultant at
Self-Employed
January 2020 - January 2021
Vice President, Investor Relations & Corporate Communications at
FibroGen, Inc.
January 2016 - January 2019
Business Advisory Board Member, strategic consultant at
Epilepsy Foundation
January 2012 - January 2016
Founder and Managing Partner at
Bcc Partners
January 2001 - January 2016
Board of Directors, and Business Advisory Board at
EPILEPSY FOUNDATION OF GEORGIA
January 2004 - January 2012
Vice President, Corporate Communications and Investor Relations at
InBios International, Inc.
January 1997 - January 2001
Senior Vice President and Director, Life Science Practice at
Burns McClellan Inc.
January 1993 - January 1997
Karen Bergman
Education
Yale University, Ba, Cum Laude With Honors And Distinction In Major
Ross School of Business, Graduate Certificate In Investor Relations
Frequently Asked Questions about Karen Bergman
What is Karen Bergman email address?
Karen Bergman's primary email address is ********@boltbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Karen Bergman work for?
Karen Bergman is a Vice President, Communications and Investor Relations at Bolt Biotherapeutics, Inc., a company specializing in Pharmaceutical preparations.
Where Karen Bergman graduated from?
Karen Bergman holds a degree in from Yale University.
How can I directly contact Karen Bergman?
To contact Karen Bergman directly, you can use the email address ********@boltbio.com. Complete contact information is available upon registration with Muraena.
Who is Karen Bergman?
Karen Bergman is a seasoned Vice President specializing in investor relations and corporate communications within the biopharmaceutical and life sciences sectors. With a robust background in crafting strategic narratives and executing high-impact initiatives, she has successfully guided companies from private stages to public offerings. Her expertise encompasses a wide range of areas, including crisis communications, corporate branding, and stakeholder management. Karen's leadership style emphasizes collaboration and strategic foresight, making her a trusted advisor to C-suite executives. She has a proven track record of enhancing corporate reputation and investor engagement, particularly in competitive environments. Her educational foundation from Yale University and the University of Michigan further solidifies her professional acumen. Beyond her corporate roles, she has served on advisory boards, contributing to the advancement of industry standards. Karen's passion for life sciences drives her commitment to innovative communication strategies that resonate with diverse audiences.
Karen`s contact details
********@boltbio.com
********@fibrogen.com
Colleagues
COO/CBO
Vice President of Biometrics
Scientific Co-founder & Senior Vice President, Research
Senior VP, Pharmaceutical Operations
VP of Finance, PAO
Senior Vice President Clinical Development
President & CEO
Vice President, Portfolio and Program Management